New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 27, 2013
09:21 EDTTIF, CPRX, LDK, JCP, SAFM, DSW, BWS, HITK, AKRX, MOV, NOKOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Tiffany & Co. (TIF), up 1%... Movado Group (MOV), up 5%... Brown Shoe Company (BWS), up 4.4%... DSW (DSW), up 2%... Sanderson Farms (SAFM), up 2.3%... ALSO HIGHER: Catalyst Pharmaceutical (CPRX), up 64% after receiving breakthrough therapy designation by FDA... Akorn (AKRX), up 7% after agreeing to buy Hi-Tech Pharmacal (HITK). Hi-Tech also up 22%... DOWN AFTER EARNINGS: LDK Solar (LDK), down 12%. LOWER: J.C. Penney (JCP), down 2% after Bill Ackman's Pershing Square sells 39M shares... Acura Pharmaceuticals (ACUR), down 23.5% after results for a clinical trial's primary endpoint were not statistically significant... Nokia (NOK), down 3.6% after Deutsche Bank says company possibly facing another restructuring.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
September 29, 2014
18:22 EDTCPRXOn The Fly: After Hours Movers
Subscribe for More Information
17:08 EDTCPRXCatalyst Pharmaceutical up 24% after hours following positive Firdapse data
16:37 EDTTIFLone Pine Capital reports 5.3% passive stake in Tiffany
16:05 EDTCPRXCatalyst Pharmaceutical: Results from Phase 3 trial of Firdapse met co-endpoints
Catalyst Pharmaceutical announced positive top-line results from the pivotal Phase 3 clinical trial of Firdapse for the symptomatic treatment of Lambert-Eaton myasthenic syndrome. Both co-primary endpoints, quantitative myasthenia gravis score and subject global impression, demonstrated that Firdapse was significantly superior to placebo, as did a secondary endpoint for the physician's clinical global impression of improvement. This clinical trial was designed as a double blind, randomized, "withdrawal trial" in which all patients were initially treated with Firdapse during a 91 day run-in period followed by treatment with either Firdapse or placebo during a 2 week randomization period. A total of 38 patients completed the 3 month run-in period and subsequent 2 week randomization period. In a trial of this design, the clinically significant findings, when present, are worsening of symptoms in the placebo group.
16:00 EDTCPRXCatalyst Pharmaceutical trading halted, pending news
Subscribe for More Information
11:40 EDTJCPOptions with increasing implied volatility
Subscribe for More Information
10:00 EDTAKRXOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Akorn (AKRX) upgraded to Outperform from Sector Perform at RBC Capital... Alexandria Real Estate (ARE) upgraded to Buy from Hold at ISI Group... Baidu (BIDU) upgraded to Buy at UBS... Banner Corp. (BANR) upgraded to Buy from Neutral at DA Davidson... Boston Properties (BXP) upgraded to Buy from Hold at ISI Group... Brocade (BRCD) upgraded to Hold from Sell at Summit Research... Chico's FAS (CHS) upgraded to Outperform from Perform at Oppenheimer... Energy Transfer Partners (ETP) upgraded at Morgan Stanley... Equity One (EQY) upgraded to Buy from Hold at ISI Group... FedEx (FDX) upgraded to Outperform from Market Perform at Cowen... Himax (HIMX) upgraded at Craig-Hallum... Janus Capital (JNS) upgraded at Morgan Stanley... Kilroy Realty (KRC) upgraded to Buy from Hold at ISI Group... LRR Energy (LRE) upgraded to Buy from Hold at Stifel... Nationstar (NSM) upgraded at Sterne Agee... Nexstar (NXST) upgraded to Buy from Hold at Noble Financial... Nike (NKE) upgraded to Outperform from Neutral at Credit Suisse... Pearson (PSO) upgraded to Outperform from Underperform at Macquarie... Philips (PHG) upgraded to Buy from Hold at ING Group... Rent-A-Center (RCII) upgraded at KeyBanc... Rice Energy (RICE) upgraded to Buy from Accumulate at KLR Group... Sonic Automotive (SAH) upgraded to Overweight from Underweight at Morgan Stanley... Tahoe Resources (TAHO) upgraded to Outperform from Market Perform at Raymond James... Tanger Factory (SKT) upgraded to Buy from Hold at ISI Group... Universal Health (UHS) upgraded at BMO Capital... Voya Financial (VOYA) upgraded to Strong Buy from Outperform at Raymond James... Waste Management (WM) upgraded at Wedbush... Yahoo (YHOO) upgraded to Buy from Hold at Needham.
09:53 EDTCPRXCatalyst Pharmaceutical management to meet with Roth Capital
Meeting to be held in San Francisco on October 6 hosted by Roth Capital.
06:22 EDTAKRXAkorn upgraded to Outperform from Sector Perform at RBC Capital
Subscribe for More Information
September 24, 2014
08:21 EDTTIFTiffany's new CFO to unlock value through P&L initiatives, says Goldman
Goldman said Tiffany's recently appointed CFO Ralph Nicoletti is a new driver of strength and expects him to drive meaningful free-cash-flow improvement by unlocking value in the P&L. The analyst said yesterday's refinancing is just the beginning of initiatives that will unlock value and expects to see sourcing cost reductions, streamlining of lead times, and lower capex, tax rate, and interest expenses. Shares are Buy rated with a $116 price target up from $114.
September 23, 2014
09:39 EDTDSWDSW's Q3 revenues tracking below consneus, says ITG Research
Subscribe for More Information
07:54 EDTAKRXLeerink to hold a conference
Subscribe for More Information
September 22, 2014
11:38 EDTJCPStocks with call strike movement; JCP TWTR
J.C. Penney (JCP) February 12 call option implied volatility increased 5% to 45, Twitter (TWTR) January 62.5 call option implied volatility increased 4% to 46 according to IVolatility.
September 19, 2014
14:18 EDTAKRXAkorn competition settlement over VersaPharm deal approved by FTC
Subscribe for More Information
11:48 EDTBWSBrown Shoe division expands to West Coast
Subscribe for More Information
07:23 EDTNOKFCC to hold a roundtable
Open Internet Roundtable: Technological Aspects will consider the technical aspects of ensuring an Open Internet, including questions of scope, transparency, blocking, mobile networks, and reasonable network management and is being held at FCC Washington, D.C. offices on September 19 at 1:30 pm. Webcast Link
September 18, 2014
16:02 EDTBWSBrown Shoe Company invest in Jack Erwin
Subscribe for More Information
13:20 EDTBWSBrown Shoe leads investment in online shoe startup, Re/code reports
Brown Shoe Company is leading a $9M investment in Jack Erwin, a New York City-based online shoe brand that began selling its footwear last year and utilizes a unique business model to sell high-end men's shoes for under $200, according to Re/code, citing an interview with Brown Shoe's CEO, Diane Sullivan. Jack Erwin had raised approximately $3M in two previous investment rounds, Re/code added. Reference Link
12:37 EDTSAFMSanderson Farms increases quarterly dividend, authorizes special dividend
Subscribe for More Information
12:07 EDTJCPStocks with call strike movement; JCP FB
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use